Related Experiment Video
Updated: Aug 13, 2026

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
Microtubule alterations and resistance to tubulin-binding agents (review)
Sima Drukman1, Maria Kavallaris
1Children's Cancer Institute Australia for Medical Research, High Street (P.O. Box 81), Randwick, NSW 2031, Australia.
Abstract:
Antimitotic agents that bind to tubulin and disrupt microtubule dynamics, such as vinca alkaloids and taxanes, are an integral part of the treatment of many human cancers. Unfortunately the clinical success of these agents can be severely hindered by the emergence of drug resistant tumour cells. In recent years interest has focused on alterations in the cellular target of antimicrotubule compounds, the tubulin/ microtubule system, and their role in drug resistance. This review will discuss tubulin/microtubule alterations associated with resistance to tubulin-binding agents. Novel antimicrotubule compounds that hold promise in the treatment of drug-resistant disease and are currently undergoing clinical evaluation will also be reviewed.
Insights
Drug resistance in cancer treatment often stems from changes in the tubulin/microtubule system. This review explores these alterations and promising new antimicrotubule drugs for resistant tumors.
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Antimitotic drugs (vinca alkaloids, taxanes) are crucial cancer treatments.
- Tumor cells can develop resistance, limiting drug efficacy.
- Alterations in the tubulin/microtubule system are increasingly recognized as a key mechanism of resistance.
Purpose of the Study:
- To review tubulin/microtubule alterations associated with resistance to tubulin-binding agents.
- To discuss novel antimicrotubule compounds for treating drug-resistant cancers.
Main Methods:
- Literature review of studies on drug resistance mechanisms.
- Analysis of clinical trial data for novel antimicrotubule agents.
Main Results:
- Tubulin/microtubule alterations are a significant factor in resistance to standard antimitotic drugs.
- Emerging antimicrotubule compounds show potential in overcoming existing resistance.
Conclusions:
- Understanding tubulin/microtubule alterations is vital for overcoming cancer drug resistance.
- New therapeutic strategies targeting the microtubule system offer hope for patients with resistant tumors.
More Related Videos
07:54Purification of Tubulin with Controlled Posttranslational Modifications and Isotypes from Limited Sources by Polymerization-Depolymerization Cycles
Published on: November 5, 2020
07:21Quantitative Microtubule Fractionation Technique to Separate Stable Microtubules, Labile Microtubules, and Free Tubulin in Mouse Tissues
Published on: November 17, 2023
Related Concept Videos
Microtubule Instability
Microtubule Formation
Destabilization of Microtubules
Drugs that Stabilize Microtubules
Microtubule Instability
Drugs that Destabilize Microtubules